Cabotegravir (LA) for PrEP
HIV Prevention
Approved/Phase 3Active
Key Facts
About ViiV Healthcare
ViiV Healthcare is a unique, HIV-focused pharmaceutical company established as a joint venture by GSK, Pfizer, and Shionogi. It has built a leading portfolio of antiretroviral therapies, including long-acting injectable regimens, and maintains a robust pipeline aimed at treatment, prevention, and cure. The company operates with a deep commitment to the HIV community, leveraging partnerships and implementation science to address unmet needs and health disparities globally.
View full company profileTherapeutic Areas
Other HIV Prevention Drugs
| Drug | Company | Phase |
|---|---|---|
| srRNA Vaccine for HIV | Replicate Bioscience | Pre-clinical |
| GRAdHIVNE1 | ReiThera | Phase 1 |